Status:

RECRUITING

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

Lead Sponsor:

University Hospital of Cologne

Conditions:

Atrial Functional Mitral Regurgitation

Mitral Insufficiency

Eligibility:

All Genders

18+ years

Brief Summary

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Eligibility Criteria

Inclusion

  • functional mitral regurgitation
  • left ventricular ejection fraction ≥50%

Exclusion

  • age under 18 years
  • known regional wall movement disorders

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2035

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06911099

Start Date

January 1 2010

End Date

December 31 2035

Last Update

April 6 2025

Active Locations (22)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (22 locations)

1

Montefiore Medical Center

The Bronx, New York, United States

2

St. Michael's Hospital

Toronto, Canada

3

Bordeaux University Hospital

Bordeaux, France

4

University Hospital Center of Nantes

Nantes, France

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR) | DecenTrialz